| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC1401 |
| Trial ID | NCT01475058 |
| Disease | Mantle Cell Lymphoma | Diffuse Large B-Cell Lymphoma | Acute Lymphoblastic Leukemia | Chronic Lymphocytic Leukemia |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD19 CAR-T cells |
| Phase | Phase1|Phase2 |
| Recruitment status | Completed |
| Title | CD19 CAR T Cells for B Cell Malignancies After Allogeneic Transplant |
| Year | 2012 |
| Country | United States |
| Company sponsor | Fred Hutchinson Cancer Center |
| Other ID(s) | 2494.00|NCI-2011-01819|2494.00|P30CA015704|R01CA136551 |
| Cohort 1 | |||||||||
|
|||||||||